LeMaitre Vascular LMAT Inventory And Other Deferred Costs
Inventory And Other Deferred Costs at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept ck0001158895:InventoryAndOtherDeferredCosts.
The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about LeMaitre Vascular's inventory and other deferred costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is LeMaitre Vascular's inventory and other deferred costs?
- LeMaitre Vascular (LMAT) reported inventory and other deferred costs of $70.82M in Q1 2026.
- What does inventory and other deferred costs mean?
- This metric represents the aggregate value of raw materials, work-in-progress, and finished medical device inventory, alongside associated deferred costs expected to be realized within one year. It reflects the capital tied up in the supply chain and manufacturing pipeline necessary to support the distribution of vascular surgical products. Monitoring this balance helps assess inventory turnover efficiency and the risk of obsolescence in specialized medical device markets.